Harald Grut
Seyed H Moosavi,
Kushtrim Kryeziu,
Ina A. Eilertsen,
Luis Nunes,
Merete Hektoen,
Barbara Niederdorfer
et al.:
Molecular prognostic factors for liver transplantation of unresectable metastatic colorectal cancer
Nadide Mutlukoca Stern,
Lars Tore Gyland Mikalsen,
Svein Dueland,
Anselm Schulz,
Pål Dag Line,
Caroline Stokke
et al.:
The prognostic value of [18F]FDG PET/CT texture analysis prior to transplantation for unresectable colorectal liver metastases
Harald Grut,
Pål Dag Line,
Trygve Syversveen,
Svein Dueland
:
Metabolic Tumor Volume from 18F-FDG PET/CT in Combination with Radiologic Measurements to Predict Long-Term Survival Following Transplantation for Colorectal Liver Metastases
Svein Dueland,
Tor Magnus Smedman,
Trygve Syversveen,
Harald Grut,
Morten Hagness,
Pål Dag Line
:
Long-Term Survival, Prognostic Factors, and Selection of Patients with Colorectal Cancer for Liver Transplant: A Nonrandomized Controlled Trial
Svein Dueland,
Tor Magnus Smedman,
Harald Grut,
Trygve Syversveen,
Lars Hilmar Jørgensen,
Pål Dag Line
:
PET-Uptake in Liver Metastases as Method to Predict Tumor Biological Behavior in Patients Transplanted for Colorectal Liver Metastases Developing Lung Recurrence
Harald Grut,
Pål Dag Line,
Trygve Syversveen,
Svein Dueland
:
Metabolic tumor volume predicts long-term survival after transplantation for unresectable colorectal liver metastases: 15 years of experience from the SECA study
Harald Grut,
Pål Dag Line,
Knut Jørgen Labori,
Anselm Schulz,
Svein Dueland
:
Survival after liver resection and liver transplantation for colorectal liver metastases: a comparative analysis stratified by metabolic tumor volume assessed by 18F-FDG PET/CT
Svein Dueland,
Trygve Syversveen,
Morten Hagness,
Harald Grut,
Pål Dag Line
:
Liver transplantation for advanced liver-only colorectal metastases
Inger Johanne Eide,
Harald Grut,
Åslaug Helland,
Simon Ekman,
Jens Benn Sørensen,
Karin Holmskov Hansen
et al.:
Intracranial effect of osimertinib in relapsed EGFR-mutated T790M-positive and -negative non-small cell lung cancer patients: results from a phase II study
Svein Dueland,
Tor M. Smedman,
Bård Ingvald Røsok,
Harald Grut,
Trygve Syversveen,
Lars Hilmar Jørgensen
et al.:
Treatment of relapse and survival outcomes after liver transplantation in patients with colorectal liver metastases
Svein Dueland,
Trygve Syversveen,
Jon Magnus Aarstrand Solheim,
Steinar Solberg,
Harald Grut,
Bjørn Atle Bjørnbeth
et al.:
Survival following liver transplantation for patients with nonresectable liver-only colorectal metastases
Tor Magnus Smedman,
Pål Dag Line,
Morten Hagness,
Trygve Syversveen,
Harald Grut,
Svein Dueland
:
Liver transplantation for unresectable colorectal liver metastases in patients and donors with extended criteria (SECA-II arm D study)
Harald Grut,
Nadide Stern,
Svein Dueland,
Knut Jørgen Labori,
Johann Baptist Dormagen,
Anselm Schulz
:
Preoperative Preoperative 18F-FDG PET/computed tomography predicts survival following resection for colorectal liver metastases
Svein Dueland,
Harald Grut,
Trygve Syversveen,
Morten Hagness,
Pål Dag Line
:
Selection criteria related to long-term survival following liver transplantation for colorectal liver metastasis
Harald Grut,
Steinar Solberg,
Therese Seierstad,
Mona-Elisabeth Rootwelt-Revheim,
Tor Skatvedt Egge,
Stein Gunnar Larsen
et al.:
Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases
Harald Grut,
Mona-Elisabeth Rootwelt-Revheim,
Pål Dag Line,
Svein Dueland
:
Importance of 18F-FDG PET/CT to select patients with nonresectable colorectal liver metastases for liver transplantation
Harald Grut,
Svein Dueland,
Pål Dag Line,
Mona-Elisabeth Rootwelt-Revheim
:
The prognostic value of 18F–FDG PET/CT prior to liver transplantation for nonresectable colorectal liver metastases
The 50 latest publications is shown on this page. See all publications in Cristin here →